Process View
A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "viral process"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
THOC4 | THO complex 4 | 1.000 | ||
IFI44 | interferon-induced protein 44 | 0.998 | ||
THOC5 | THO complex 5 | 0.997 | ||
SP110 | SP110 nuclear body protein | 0.997 | Human | |
OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 0.995 | Human | |
NCBP1 | nuclear cap binding protein subunit 1, 80kDa | 0.995 | Fly | |
TP53 | tumor protein p53 | 0.994 | ||
SP1 | Sp1 transcription factor | 0.993 | ||
HDAC1 | histone deacetylase 1 | 0.992 | ||
DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 0.990 | ||
SMAD1 | SMAD family member 1 | 0.989 | Human | |
WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.987 | Human | |
IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 | 0.984 | Human | |
SMAD3 | SMAD family member 3 | 0.982 | ||
TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.979 | ||
PLSCR1 | phospholipid scramblase 1 | 0.971 | ||
RNF11 | ring finger protein 11 | 0.968 | ||
EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0.966 | ||
MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.965 | ||
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.963 | ||
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | 0.961 | ||
CREBBP | CREB binding protein | 0.956 | Human | |
IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.956 | ||
IL8 | interleukin 8 | 0.949 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.946 | Human | |
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.943 | ||
OAS1 | 2',5'-oligoadenylate synthetase 1, 40/46kDa | 0.940 | ||
MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | 0.913 | ||
RARA | retinoic acid receptor, alpha | 0.906 | ||
SMAD2 | SMAD family member 2 | 0.898 | Human | |
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.890 | Human | |
PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 0.887 | ||
BAX | BCL2-associated X protein | 0.872 | Human | |
RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.869 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.868 | Human | |
UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.862 | ||
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.862 | Human | |
ENG | endoglin | 0.859 | ||
GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.849 | ||
IFI44L | interferon-induced protein 44-like | 0.849 | ||
SP100 | SP100 nuclear antigen | 0.846 | ||
SMAD4 | SMAD family member 4 | 0.845 | Human | |
BCL2 | B-cell CLL/lymphoma 2 | 0.845 | Human Mouse | |
BCL2L1 | BCL2-like 1 | 0.844 | ||
OASL | 2'-5'-oligoadenylate synthetase-like | 0.838 | ||
MX2 | myxovirus (influenza virus) resistance 2 (mouse) | 0.834 | Human | |
PARP1 | poly (ADP-ribose) polymerase 1 | 0.834 | ||
RRAGC | Ras-related GTP binding C | 0.833 | ||
IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.828 | ||
GSK3B | glycogen synthase kinase 3 beta | 0.824 | ||
GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.822 | ||
ARID1B | AT rich interactive domain 1B (SWI1-like) | 0.811 | ||
JUN | jun proto-oncogene | 0.808 | ||
TSG101 | tumor susceptibility gene 101 | 0.797 | ||
PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.792 | Human | |
DPP4 | dipeptidyl-peptidase 4 | 0.790 | ||
CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.775 | Human | |
PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.765 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.731 | ||
SMAD5 | SMAD family member 5 | 0.729 | Human | |
IFI35 | interferon-induced protein 35 | 0.706 | ||
THOC1 | THO complex 1 | 0.703 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.686 | ||
DICER1 | dicer 1, ribonuclease type III | 0.685 | Mouse | |
IFIH1 | interferon induced with helicase C domain 1 | 0.670 | ||
CCL8 | chemokine (C-C motif) ligand 8 | 0.665 | Human | |
ATG12 | ATG12 autophagy related 12 homolog (S. cerevisiae) | 0.657 | ||
FHL2 | four and a half LIM domains 2 | 0.638 | ||
UBE2D4 | ubiquitin-conjugating enzyme E2D 4 (putative) | 0.633 | ||
SKIL | SKI-like oncogene | 0.632 | ||
AXL | AXL receptor tyrosine kinase | 0.627 | ||
PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) | 0.616 | ||
SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.596 | Human | |
CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.575 | Human | |
THOC2 | THO complex 2 | 0.572 | ||
SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.564 | ||
HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.563 | Mouse | |
TRIM21 | tripartite motif containing 21 | 0.557 | ||
IL1B | interleukin 1, beta | 0.554 | ||
IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.554 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.547 | Human | |
PROX1 | prospero homeobox 1 | 0.546 | ||
PML | promyelocytic leukemia | 0.543 | ||
TRIM22 | tripartite motif containing 22 | 0.540 | Human | |
CCL20 | chemokine (C-C motif) ligand 20 | 0.539 | Human | |
UBE2U | ubiquitin-conjugating enzyme E2U (putative) | 0.525 | ||
IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 | 0.523 | Human | |
INSR | insulin receptor | 0.522 | ||
HMGA1 | high mobility group AT-hook 1 | 0.513 | Human | |
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.510 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.509 | ||
SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.508 | ||
UTRN | utrophin | 0.508 | ||
XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | 0.503 | ||
RBM8A | RNA binding motif protein 8A | 0.479 | ||
HDAC2 | histone deacetylase 2 | 0.476 | Human | |
TRIM63 | tripartite motif containing 63 | 0.476 | Human | |
GOLGA2 | golgin A2 | 0.475 | ||
YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.469 | ||
THOC3 | THO complex 3 | 0.452 | ||
PDCD6IP | programmed cell death 6 interacting protein | 0.446 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.445 | ||
TRIM41 | tripartite motif containing 41 | 0.443 | Human | |
GBP1 | guanylate binding protein 1, interferon-inducible | 0.441 | ||
DTX3L | deltex 3-like (Drosophila) | 0.440 | ||
FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.439 | ||
OAS3 | 2'-5'-oligoadenylate synthetase 3, 100kDa | 0.438 | ||
TRIM39 | tripartite motif containing 39 | 0.437 | Human | |
ISG15 | ISG15 ubiquitin-like modifier | 0.433 | ||
PARP12 | poly (ADP-ribose) polymerase family, member 12 | 0.430 | Human | |
SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 0.428 | ||
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.424 | Mouse | |
STX8 | syntaxin 8 | 0.414 | ||
RBBP4 | retinoblastoma binding protein 4 | 0.405 | ||
HNF4A | hepatocyte nuclear factor 4, alpha | 0.402 | Human | |
SUMO1 | SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) | 0.401 | ||
ADAR | adenosine deaminase, RNA-specific | 0.401 | ||
ATXN3 | ataxin 3 | 0.392 | ||
BAK1 | BCL2-antagonist/killer 1 | 0.390 | Human | |
FBXL15 | F-box and leucine-rich repeat protein 15 | 0.381 | ||
PARP9 | poly (ADP-ribose) polymerase family, member 9 | 0.373 | Human | |
ATG3 | ATG3 autophagy related 3 homolog (S. cerevisiae) | 0.368 | ||
CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.355 | Human | |
IFIT5 | interferon-induced protein with tetratricopeptide repeats 5 | 0.351 | Human | |
DYNC1I2 | dynein, cytoplasmic 1, intermediate chain 2 | 0.351 | ||
GFM1 | G elongation factor, mitochondrial 1 | 0.350 | ||
XAF1 | XIAP associated factor 1 | 0.346 | ||
UBE2D3 | ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) | 0.344 | ||
SMAD7 | SMAD family member 7 | 0.330 | Human | |
PVRL4 | poliovirus receptor-related 4 | 0.321 | ||
TRIM33 | tripartite motif containing 33 | 0.320 | Human | |
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.314 | ||
RAB6A | RAB6A, member RAS oncogene family | 0.312 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.304 | Human | |
TRIM43 | tripartite motif containing 43 | 0.299 | ||
TRIM14 | tripartite motif containing 14 | 0.298 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.298 | ||
HDGF | hepatoma-derived growth factor | 0.295 | ||
BST2 | bone marrow stromal cell antigen 2 | 0.291 | ||
BAD | BCL2-associated agonist of cell death | 0.287 | ||
CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.283 | Human | |
IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 | 0.281 | ||
THBS1 | thrombospondin 1 | 0.273 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.273 | ||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.270 | Human | |
TRIM5 | tripartite motif containing 5 | 0.267 | ||
CCR5 | chemokine (C-C motif) receptor 5 | 0.264 | ||
NCOA1 | nuclear receptor coactivator 1 | 0.261 | ||
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.254 | ||
UBD | ubiquitin D | 0.254 | ||
RAB14 | RAB14, member RAS oncogene family | 0.253 | ||
WRN | Werner syndrome, RecQ helicase-like | 0.245 | ||
IFI16 | interferon, gamma-inducible protein 16 | 0.244 | ||
PDCD6 | programmed cell death 6 | 0.243 | ||
ILF3 | interleukin enhancer binding factor 3, 90kDa | 0.243 | Mouse | |
SOX10 | SRY (sex determining region Y)-box 10 | 0.237 | ||
IFI27 | interferon, alpha-inducible protein 27 | 0.235 | ||
CHTOP | chromatin target of PRMT1 | 0.235 | ||
PVRL3 | poliovirus receptor-related 3 | 0.232 | Human | |
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.225 | ||
MED25 | mediator complex subunit 25 | 0.224 | ||
USP9X | ubiquitin specific peptidase 9, X-linked | 0.223 | ||
MAGEA4 | melanoma antigen family A, 4 | 0.222 | ||
USF1 | upstream transcription factor 1 | 0.222 | ||
ITGB4 | integrin, beta 4 | 0.222 | ||
MED15 | mediator complex subunit 15 | 0.222 | ||
PAX3 | paired box 3 | 0.221 | ||
BCL2A1 | BCL2-related protein A1 | 0.214 | ||
IFI6 | interferon, alpha-inducible protein 6 | 0.214 | ||
TMEM173 | transmembrane protein 173 | 0.212 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.211 | Human | |
ING2 | inhibitor of growth family, member 2 | 0.211 | ||
IRF9 | interferon regulatory factor 9 | 0.211 | ||
TRIM8 | tripartite motif containing 8 | 0.209 | ||
KDM6A | lysine (K)-specific demethylase 6A | 0.202 | ||
C19orf66 | chromosome 19 open reading frame 66 | 0.196 | ||
PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.196 | ||
NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.195 | ||
CMPK2 | cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial | 0.195 | ||
PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.193 | ||
TRIM26 | tripartite motif containing 26 | 0.191 | ||
EP300 | E1A binding protein p300 | 0.191 | ||
TLN1 | talin 1 | 0.190 | ||
IRS1 | insulin receptor substrate 1 | 0.189 | ||
PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.188 | ||
IL7R | interleukin 7 receptor | 0.188 | ||
NCOR1 | nuclear receptor corepressor 1 | 0.187 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.186 | ||
APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.181 | ||
TRIM25 | tripartite motif containing 25 | 0.178 | ||
EIF4A3 | eukaryotic translation initiation factor 4A3 | 0.178 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.177 | ||
ATF2 | activating transcription factor 2 | 0.175 | Human | |
ROCK1 | Rho-associated, coiled-coil containing protein kinase 1 | 0.175 | ||
FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.174 | ||
PRKRA | protein kinase, interferon-inducible double stranded RNA dependent activator | 0.174 | Human | |
MOV10 | Mov10, Moloney leukemia virus 10, homolog (mouse) | 0.173 | ||
SMARCA5 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 | 0.170 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.170 | ||
TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.168 | ||
STAM | signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 | 0.166 | ||
POU2F1 | POU class 2 homeobox 1 | 0.165 | Human | |
IGF1R | insulin-like growth factor 1 receptor | 0.164 | Human | |
PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.163 | ||
XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.160 | ||
PARP14 | poly (ADP-ribose) polymerase family, member 14 | 0.160 | Human | |
USP54 | ubiquitin specific peptidase 54 | 0.159 | ||
STAMBP | STAM binding protein | 0.157 | ||
LAMP3 | lysosomal-associated membrane protein 3 | 0.155 | ||
MYD88 | myeloid differentiation primary response gene (88) | 0.154 | ||
IRF7 | interferon regulatory factor 7 | 0.154 | ||
DHX58 | DEXH (Asp-Glu-X-His) box polypeptide 58 | 0.153 | ||
PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 0.152 | ||
PSME2 | proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | 0.152 | ||
TGFBR1 | transforming growth factor, beta receptor 1 | 0.151 | ||
ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.151 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.150 | ||
SUMO2 | SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) | 0.149 | ||
CPSF6 | cleavage and polyadenylation specific factor 6, 68kDa | 0.148 | ||
XRN2 | 5'-3' exoribonuclease 2 | 0.148 | ||
RPA1 | replication protein A1, 70kDa | 0.147 | ||
ZNFX1 | zinc finger, NFX1-type containing 1 | 0.145 | ||
DDX60 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 | 0.145 | ||
CCL7 | chemokine (C-C motif) ligand 7 | 0.145 | Human | |
IDE | insulin-degrading enzyme | 0.144 | ||
LIN28B | lin-28 homolog B (C. elegans) | 0.143 | ||
RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.143 | ||
SFPQ | splicing factor proline/glutamine-rich | 0.143 | ||
USF2 | upstream transcription factor 2, c-fos interacting | 0.143 | Human | |
NBR1 | neighbor of BRCA1 gene 1 | 0.141 | ||
CHMP1A | chromatin modifying protein 1A | 0.139 | ||
JUNB | jun B proto-oncogene | 0.139 | Human | |
IL10 | interleukin 10 | 0.139 | ||
GCC1 | GRIP and coiled-coil domain containing 1 | 0.139 | ||
HERC5 | hect domain and RLD 5 | 0.138 | ||
PI3 | peptidase inhibitor 3, skin-derived | 0.138 | ||
CCL13 | chemokine (C-C motif) ligand 13 | 0.137 | Human | |
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.136 | ||
UBC | ubiquitin C | 0.136 | ||
EIF2C2 | eukaryotic translation initiation factor 2C, 2 | 0.135 | ||
HLA-E | major histocompatibility complex, class I, E | 0.135 | ||
MAPK8 | mitogen-activated protein kinase 8 | 0.133 | ||
CHMP1B | chromatin modifying protein 1B | 0.132 | ||
NAMPT | nicotinamide phosphoribosyltransferase | 0.132 | ||
SS18 | synovial sarcoma translocation, chromosome 18 | 0.131 | ||
NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.130 | ||
SMAD6 | SMAD family member 6 | 0.129 | Human | |
RB1CC1 | RB1-inducible coiled-coil 1 | 0.129 | ||
VPS24 | vacuolar protein sorting 24 homolog (S. cerevisiae) | 0.129 | ||
OCIAD1 | OCIA domain containing 1 | 0.126 | ||
RRAS | related RAS viral (r-ras) oncogene homolog | 0.126 | ||
RAB5A | RAB5A, member RAS oncogene family | 0.126 | ||
TDG | thymine-DNA glycosylase | 0.125 | ||
TCF12 | transcription factor 12 | 0.124 | ||
IL15RA | interleukin 15 receptor, alpha | 0.123 | ||
NCOR2 | nuclear receptor corepressor 2 | 0.123 | ||
SOX7 | SRY (sex determining region Y)-box 7 | 0.123 | ||
MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.122 | ||
SPOP | speckle-type POZ protein | 0.121 | ||
SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.121 | ||
FOXD3 | forkhead box D3 | 0.121 | ||
FOSL1 | FOS-like antigen 1 | 0.120 | ||
LGALS9 | lectin, galactoside-binding, soluble, 9 | 0.119 | ||
ATF3 | activating transcription factor 3 | 0.118 | ||
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.117 | ||
IER2 | immediate early response 2 | 0.116 | ||
CCL19 | chemokine (C-C motif) ligand 19 | 0.115 | Human | |
LRSAM1 | leucine rich repeat and sterile alpha motif containing 1 | 0.113 | ||
DHX30 | DEAH (Asp-Glu-Ala-His) box polypeptide 30 | 0.112 | ||
IFNG | interferon, gamma | 0.112 | ||
IDO1 | indoleamine 2,3-dioxygenase 1 | 0.112 | ||
TK1 | thymidine kinase 1, soluble | 0.111 | ||
ZMYM2 | zinc finger, MYM-type 2 | 0.111 | ||
SOD2 | superoxide dismutase 2, mitochondrial | 0.110 | ||
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.109 | ||
BCL6 | B-cell CLL/lymphoma 6 | 0.108 | ||
STX7 | syntaxin 7 | 0.107 | ||
TGFB1 | transforming growth factor, beta 1 | 0.106 | ||
TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | 0.106 | ||
DMD | dystrophin | 0.106 | ||
MAPK14 | mitogen-activated protein kinase 14 | 0.105 | ||
ZFP28 | zinc finger protein 28 homolog (mouse) | 0.104 | ||
CHD4 | chromodomain helicase DNA binding protein 4 | 0.104 | ||
SOX2 | SRY (sex determining region Y)-box 2 | 0.104 | ||
RAD23B | RAD23 homolog B (S. cerevisiae) | 0.103 | Human | |
GATAD2B | GATA zinc finger domain containing 2B | 0.103 | ||
RUSC2 | RUN and SH3 domain containing 2 | 0.103 | ||
CARHSP1 | calcium regulated heat stable protein 1, 24kDa | 0.102 | ||
EFCAB4B | EF-hand calcium binding domain 4B | 0.102 | ||
GHR | growth hormone receptor | 0.101 | ||
RSAD2 | radical S-adenosyl methionine domain containing 2 | 0.101 | ||
CLTC | clathrin, heavy chain (Hc) | 0.101 | ||
IL32 | interleukin 32 | 0.100 | ||
WWP1 | WW domain containing E3 ubiquitin protein ligase 1 | 0.100 | Human | |
ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.100 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.100 | ||
PECAM1 | platelet/endothelial cell adhesion molecule | 0.099 | ||
RAB2A | RAB2A, member RAS oncogene family | 0.099 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.099 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.097 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.096 | ||
NONO | non-POU domain containing, octamer-binding | 0.095 | ||
CCL3 | chemokine (C-C motif) ligand 3 | 0.095 | ||
UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.094 | ||
POU5F1 | POU class 5 homeobox 1 | 0.094 | Human | |
BRCA1 | breast cancer 1, early onset | 0.093 | ||
RBBP5 | retinoblastoma binding protein 5 | 0.092 | ||
SELE | selectin E | 0.090 | ||
RHOA | ras homolog gene family, member A | 0.090 | ||
SRGN | serglycin | 0.089 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.089 | ||
ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | 0.088 | ||
CHMP5 | chromatin modifying protein 5 | 0.087 | ||
CHMP2A | chromatin modifying protein 2A | 0.087 | ||
CHERP | calcium homeostasis endoplasmic reticulum protein | 0.087 | ||
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.086 | ||
CEP55 | centrosomal protein 55kDa | 0.085 | ||
ESR1 | estrogen receptor 1 | 0.085 | ||
NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.085 | ||
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.084 | Rat | |
TUBA1B | tubulin, alpha 1b | 0.084 | ||
BAG2 | BCL2-associated athanogene 2 | 0.084 | ||
TYMP | thymidine phosphorylase | 0.084 | ||
CAPN7 | calpain 7 | 0.083 | ||
DHX9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 | 0.083 | ||
PDIA3 | protein disulfide isomerase family A, member 3 | 0.083 | ||
TAF13 | TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa | 0.083 | ||
TRIM17 | tripartite motif containing 17 | 0.082 | Human | |
THOC6 | THO complex 6 homolog (Drosophila) | 0.082 | ||
STAU1 | staufen, RNA binding protein, homolog 1 (Drosophila) | 0.082 | ||
VTI1B | vesicle transport through interaction with t-SNAREs homolog 1B (yeast) | 0.081 | ||
UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.080 | ||
C17orf85 | chromosome 17 open reading frame 85 | 0.080 | ||
CH25H | cholesterol 25-hydroxylase | 0.080 | ||
TRADD | TNFRSF1A-associated via death domain | 0.079 | ||
TUBB3 | tubulin, beta 3 | 0.079 | ||
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.079 | ||
TARBP2 | TAR (HIV-1) RNA binding protein 2 | 0.079 | ||
TMSB4X | thymosin beta 4, X-linked | 0.079 | ||
ZNF263 | zinc finger protein 263 | 0.079 | ||
DNAJB2 | DnaJ (Hsp40) homolog, subfamily B, member 2 | 0.078 | ||
UBL7 | ubiquitin-like 7 (bone marrow stromal cell-derived) | 0.078 | ||
TRAF4 | TNF receptor-associated factor 4 | 0.078 | ||
TTN | titin | 0.078 | ||
MASP2 | mannan-binding lectin serine peptidase 2 | 0.078 | ||
UBA3 | ubiquitin-like modifier activating enzyme 3 | 0.078 | ||
CBX3 | chromobox homolog 3 | 0.078 | ||
SAMD9 | sterile alpha motif domain containing 9 | 0.078 | ||
PTPRZ1 | protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | 0.077 | ||
ELF1 | E74-like factor 1 (ets domain transcription factor) | 0.076 | ||
TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.076 | ||
RNF111 | ring finger protein 111 | 0.076 | ||
TJP1 | tight junction protein 1 (zona occludens 1) | 0.075 | ||
PPP1CB | protein phosphatase 1, catalytic subunit, beta isozyme | 0.074 | ||
MECP2 | methyl CpG binding protein 2 (Rett syndrome) | 0.074 | ||
BTN3A2 | butyrophilin, subfamily 3, member A2 | 0.073 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.073 | ||
DMBT1 | deleted in malignant brain tumors 1 | 0.073 | ||
NFYA | nuclear transcription factor Y, alpha | 0.073 | ||
OSBPL9 | oxysterol binding protein-like 9 | 0.073 | ||
DYNLT3 | dynein, light chain, Tctex-type 3 | 0.072 | Human | |
SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.072 | ||
JUND | jun D proto-oncogene | 0.072 | Human | |
TAPBP | TAP binding protein (tapasin) | 0.072 | ||
SRPK2 | SRSF protein kinase 2 | 0.072 | ||
PSEN1 | presenilin 1 | 0.071 | ||
RBM14 | RNA binding motif protein 14 | 0.071 | ||
PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.071 | ||
BCR | breakpoint cluster region | 0.071 | ||
TRIM32 | tripartite motif containing 32 | 0.071 | ||
SRPK1 | SRSF protein kinase 1 | 0.070 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.070 | ||
SIRT1 | sirtuin 1 | 0.070 | ||
MEPCE | methylphosphate capping enzyme | 0.070 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.070 | ||
RNR2 | l-rRNA | 0.070 | ||
GRB10 | growth factor receptor-bound protein 10 | 0.070 | ||
MAP2K7 | mitogen-activated protein kinase kinase 7 | 0.069 | ||
XIAP | X-linked inhibitor of apoptosis | 0.069 | ||
STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.069 | ||
GOLGA1 | golgin A1 | 0.068 | ||
TOP2A | topoisomerase (DNA) II alpha 170kDa | 0.068 | ||
HIPK2 | homeodomain interacting protein kinase 2 | 0.068 | ||
IER3 | immediate early response 3 | 0.068 | ||
EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.068 | ||
RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.068 | ||
NLK | nemo-like kinase | 0.067 | ||
FPR3 | formyl peptide receptor 3 | 0.067 | ||
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.067 | ||
MAGEA2 | melanoma antigen family A, 2 | 0.067 | ||
GLIS2 | GLIS family zinc finger 2 | 0.067 | ||
NFYC | nuclear transcription factor Y, gamma | 0.067 | ||
UBQLN1 | ubiquilin 1 | 0.066 | ||
CCL1 | chemokine (C-C motif) ligand 1 | 0.066 | Human | |
DCUN1D1 | DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) | 0.066 | ||
SUMO3 | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) | 0.066 | ||
C16orf70 | chromosome 16 open reading frame 70 | 0.066 | ||
RNF41 | ring finger protein 41 | 0.065 | ||
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.065 | ||
CCR4 | chemokine (C-C motif) receptor 4 | 0.065 | ||
STRN4 | striatin, calmodulin binding protein 4 | 0.065 | ||
ABTB1 | ankyrin repeat and BTB (POZ) domain containing 1 | 0.064 | ||
COIL | coilin | 0.063 | ||
ILF2 | interleukin enhancer binding factor 2, 45kDa | 0.063 | ||
CENPB | centromere protein B, 80kDa | 0.063 | ||
GLTPD1 | glycolipid transfer protein domain containing 1 | 0.063 | ||
PIAS1 | protein inhibitor of activated STAT, 1 | 0.063 | ||
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | 0.062 | ||
NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.062 | ||
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.062 | ||
SAMD9L | sterile alpha motif domain containing 9-like | 0.062 | ||
TOP2B | topoisomerase (DNA) II beta 180kDa | 0.062 | Human | |
DDX23 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 | 0.062 | ||
MARCH5 | membrane-associated ring finger (C3HC4) 5 | 0.061 | ||
ACTL6A | actin-like 6A | 0.061 | ||
PF4 | platelet factor 4 | 0.061 | ||
AXIN1 | axin 1 | 0.061 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.061 | ||
RGS1 | regulator of G-protein signaling 1 | 0.060 | ||
MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.060 | ||
RNF144B | ring finger protein 144B | 0.060 | ||
CASP6 | caspase 6, apoptosis-related cysteine peptidase | 0.060 | ||
SNRPA | small nuclear ribonucleoprotein polypeptide A | 0.060 | ||
MLKL | mixed lineage kinase domain-like | 0.060 | ||
PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 0.059 | ||
LY6E | lymphocyte antigen 6 complex, locus E | 0.059 | ||
DUS2L | dihydrouridine synthase 2-like, SMM1 homolog (S. cerevisiae) | 0.059 | ||
ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.059 | ||
TCF4 | transcription factor 4 | 0.059 | ||
WDYHV1 | WDYHV motif containing 1 | 0.059 | ||
TNF | tumor necrosis factor | 0.059 | ||
PHF11 | PHD finger protein 11 | 0.059 | ||
PYCARD | PYD and CARD domain containing | 0.058 | ||
EGR1 | early growth response 1 | 0.058 | ||
NCL | nucleolin | 0.058 | ||
DYDC1 | DPY30 domain containing 1 | 0.058 | ||
CD83 | CD83 molecule | 0.058 | ||
TNIK | TRAF2 and NCK interacting kinase | 0.058 | ||
RABAC1 | Rab acceptor 1 (prenylated) | 0.058 | ||
SPG21 | spastic paraplegia 21 (autosomal recessive, Mast syndrome) | 0.058 | ||
UBQLN2 | ubiquilin 2 | 0.057 | ||
USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.057 | ||
RTP4 | receptor (chemosensory) transporter protein 4 | 0.057 | ||
RAB8A | RAB8A, member RAS oncogene family | 0.056 | ||
EMD | emerin | 0.056 | ||
DTNA | dystrobrevin, alpha | 0.055 | ||
RBBP7 | retinoblastoma binding protein 7 | 0.055 | ||
EIF2C1 | eukaryotic translation initiation factor 2C, 1 | 0.055 | ||
IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.055 | ||
CD80 | CD80 molecule | 0.055 | ||
FBF1 | Fas (TNFRSF6) binding factor 1 | 0.055 | ||
TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | 0.055 | ||
SSRP1 | structure specific recognition protein 1 | 0.055 | ||
HMGB1 | high mobility group box 1 | 0.055 | ||
PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.054 | ||
AR | androgen receptor | 0.054 | ||
OSMR | oncostatin M receptor | 0.054 | ||
BATF2 | basic leucine zipper transcription factor, ATF-like 2 | 0.054 | ||
IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.053 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.053 | ||
PTTG1 | pituitary tumor-transforming 1 | 0.053 | ||
ZNF431 | zinc finger protein 431 | 0.053 | ||
MID1 | midline 1 (Opitz/BBB syndrome) | 0.053 | Human | |
INHBA | inhibin, beta A | 0.053 | ||
EED | embryonic ectoderm development | 0.053 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.053 | ||
YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.052 | ||
SLAMF8 | SLAM family member 8 | 0.052 | ||
RRAGD | Ras-related GTP binding D | 0.052 | ||
IRS2 | insulin receptor substrate 2 | 0.052 | ||
HNRNPAB | heterogeneous nuclear ribonucleoprotein A/B | 0.052 | ||
EPHB2 | EPH receptor B2 | 0.051 | ||
PXN | paxillin | 0.051 | ||
CREBZF | CREB/ATF bZIP transcription factor | 0.051 | ||
SEPT7 | septin 7 | 0.051 | ||
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.051 | ||
WDFY3 | WD repeat and FYVE domain containing 3 | 0.050 | ||
ACVRL1 | activin A receptor type II-like 1 | 0.050 | ||
PLAU | plasminogen activator, urokinase | 0.050 | ||
MYO1C | myosin IC | 0.050 | ||
IL1RN | interleukin 1 receptor antagonist | 0.050 | ||
TOP1 | topoisomerase (DNA) I | 0.050 | ||
RPS6KB1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | 0.050 | ||
MYOZ1 | myozenin 1 | 0.050 | ||
CRP | C-reactive protein, pentraxin-related | 0.049 | Human | |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | 0.049 | ||
DAXX | death-domain associated protein | 0.049 | ||
PRPF4 | PRP4 pre-mRNA processing factor 4 homolog (yeast) | 0.049 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.049 | ||
PPP1R2 | protein phosphatase 1, regulatory (inhibitor) subunit 2 | 0.049 | ||
RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.048 | ||
BBC3 | BCL2 binding component 3 | 0.048 | ||
MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.048 | ||
NUDT18 | nudix (nucleoside diphosphate linked moiety X)-type motif 18 | 0.048 | ||
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | 0.048 | ||
HNF1A | HNF1 homeobox A | 0.048 | ||
ZNF473 | zinc finger protein 473 | 0.048 | ||
FAM46A | family with sequence similarity 46, member A | 0.048 | ||
PARN | poly(A)-specific ribonuclease (deadenylation nuclease) | 0.048 | ||
SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.047 | Human | |
TBC1D10B | TBC1 domain family, member 10B | 0.047 | ||
IL1A | interleukin 1, alpha | 0.047 | ||
TAX1BP1 | Tax1 (human T-cell leukemia virus type I) binding protein 1 | 0.047 | ||
IREB2 | iron-responsive element binding protein 2 | 0.047 | ||
CALR | calreticulin | 0.047 | ||
ATG16L1 | ATG16 autophagy related 16-like 1 (S. cerevisiae) | 0.047 | Mouse | |
ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | 0.047 | ||
DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked | 0.047 | ||
MKRN3 | makorin ring finger protein 3 | 0.047 | ||
THOC7 | THO complex 7 homolog (Drosophila) | 0.046 | ||
SAFB | scaffold attachment factor B | 0.046 | ||
ATF7IP | activating transcription factor 7 interacting protein | 0.046 | ||
MICB | MHC class I polypeptide-related sequence B | 0.046 | ||
TOPORS | topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase | 0.046 | ||
SBNO2 | strawberry notch homolog 2 (Drosophila) | 0.046 | ||
TRIM27 | tripartite motif containing 27 | 0.045 | ||
PSMB10 | proteasome (prosome, macropain) subunit, beta type, 10 | 0.045 | ||
RGS16 | regulator of G-protein signaling 16 | 0.044 | ||
WFDC2 | WAP four-disulfide core domain 2 | 0.044 | ||
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.044 | ||
BIK | BCL2-interacting killer (apoptosis-inducing) | 0.044 | ||
NRP2 | neuropilin 2 | 0.044 | ||
LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.044 | ||
ZMYND11 | zinc finger, MYND-type containing 11 | 0.044 | ||
PCNA | proliferating cell nuclear antigen | 0.044 | ||
ERCC6 | excision repair cross-complementing rodent repair deficiency, complementation group 6 | 0.044 | ||
ELK1 | ELK1, member of ETS oncogene family | 0.043 | ||
ARRDC1 | arrestin domain containing 1 | 0.043 | ||
TGFB3 | transforming growth factor, beta 3 | 0.043 | ||
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.043 | ||
AIM2 | absent in melanoma 2 | 0.043 | Human | |
ANKRD13A | ankyrin repeat domain 13A | 0.043 | ||
WBP4 | WW domain binding protein 4 (formin binding protein 21) | 0.043 | ||
APOBEC3A | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | 0.043 | ||
TRANK1 | tetratricopeptide repeat and ankyrin repeat containing 1 | 0.043 | ||
TUBB8 | tubulin, beta 8 | 0.043 | ||
NIPBL | Nipped-B homolog (Drosophila) | 0.043 | ||
C2 | complement component 2 | 0.043 | ||
NMI | N-myc (and STAT) interactor | 0.043 | ||
NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.042 | ||
ACVR1B | activin A receptor, type IB | 0.042 | ||
IL2RG | interleukin 2 receptor, gamma | 0.042 | ||
SARNP | SAP domain containing ribonucleoprotein | 0.042 | ||
IL11 | interleukin 11 | 0.042 | ||
RGL1 | ral guanine nucleotide dissociation stimulator-like 1 | 0.042 | ||
SART3 | squamous cell carcinoma antigen recognized by T cells 3 | 0.042 | ||
RUNX3 | runt-related transcription factor 3 | 0.042 | ||
TRIM15 | tripartite motif containing 15 | 0.042 | ||
TRIM35 | tripartite motif containing 35 | 0.042 | ||
PPP2R2B | protein phosphatase 2, regulatory subunit B, beta | 0.042 | ||
KTN1 | kinectin 1 (kinesin receptor) | 0.042 | ||
CCR1 | chemokine (C-C motif) receptor 1 | 0.042 | ||
CSNK2A1 | casein kinase 2, alpha 1 polypeptide | 0.041 | ||
ETV7 | ets variant 7 | 0.041 | ||
VAMP7 | vesicle-associated membrane protein 7 | 0.041 | ||
IFNA4 | interferon, alpha 4 | 0.041 | ||
RNPS1 | RNA binding protein S1, serine-rich domain | 0.041 | ||
KIF20A | kinesin family member 20A | 0.041 | ||
PRR13 | proline rich 13 | 0.041 | ||
MTMR10 | myotubularin related protein 10 | 0.041 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.041 | ||
CCL22 | chemokine (C-C motif) ligand 22 | 0.041 | Human | |
SAMHD1 | SAM domain and HD domain 1 | 0.041 | ||
DARC | Duffy blood group, chemokine receptor | 0.040 | ||
ZFAND5 | zinc finger, AN1-type domain 5 | 0.040 | ||
C8A | complement component 8, alpha polypeptide | 0.040 | ||
IRF4 | interferon regulatory factor 4 | 0.040 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.040 | ||
BCL2L2 | BCL2-like 2 | 0.040 | Human | |
CCR3 | chemokine (C-C motif) receptor 3 | 0.040 | ||
CD2AP | CD2-associated protein | 0.040 | ||
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.040 | ||
NFIB | nuclear factor I/B | 0.040 | ||
BRAP | BRCA1 associated protein | 0.040 | ||
LIN28A | lin-28 homolog A (C. elegans) | 0.040 | ||
TMSB10 | thymosin beta 10 | 0.040 | ||
RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.040 | ||
ZNRF1 | zinc and ring finger 1 | 0.039 | ||
TRIM52 | tripartite motif containing 52 | 0.039 | Human | |
RXRA | retinoid X receptor, alpha | 0.039 | ||
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.039 | ||
VASP | vasodilator-stimulated phosphoprotein | 0.039 | ||
TXN | thioredoxin | 0.039 | ||
NINL | ninein-like | 0.039 | ||
ATAD2B | ATPase family, AAA domain containing 2B | 0.039 | ||
TRAF2 | TNF receptor-associated factor 2 | 0.039 | ||
UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.039 | ||
JUP | junction plakoglobin | 0.039 | ||
HGS | hepatocyte growth factor-regulated tyrosine kinase substrate | 0.039 | ||
MEP1B | meprin A, beta | 0.039 | ||
RHAG | Rh-associated glycoprotein | 0.038 | ||
DEFB4A | defensin, beta 4A | 0.038 | ||
CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.038 | ||
APTX | aprataxin | 0.038 | ||
CCT3 | chaperonin containing TCP1, subunit 3 (gamma) | 0.038 | ||
VAPA | VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa | 0.038 | Human | |
ASH2L | ash2 (absent, small, or homeotic)-like (Drosophila) | 0.038 | ||
PTMA | prothymosin, alpha | 0.038 | ||
STAT5B | signal transducer and activator of transcription 5B | 0.038 | ||
MOBKL2B | MOB1, Mps One Binder kinase activator-like 2B (yeast) | 0.038 | ||
PSMD11 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 | 0.038 | ||
MKL2 | MKL/myocardin-like 2 | 0.038 | ||
HSD3B7 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | 0.038 | ||
FN1 | fibronectin 1 | 0.038 | ||
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.038 | ||
STAT4 | signal transducer and activator of transcription 4 | 0.038 | ||
ACTG1 | actin, gamma 1 | 0.038 | ||
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.037 | ||
DCAF7 | DDB1 and CUL4 associated factor 7 | 0.037 | ||
UBL5 | ubiquitin-like 5 | 0.037 | ||
PNRC2 | proline-rich nuclear receptor coactivator 2 | 0.037 | ||
KIAA0101 | KIAA0101 | 0.037 | ||
IL21R | interleukin 21 receptor | 0.037 | ||
NEB | nebulin | 0.037 | ||
HUWE1 | HECT, UBA and WWE domain containing 1 | 0.037 | ||
MUC1 | mucin 1, cell surface associated | 0.037 | ||
JDP2 | Jun dimerization protein 2 | 0.037 | ||
KLC1 | kinesin light chain 1 | 0.037 | ||
EIF3B | eukaryotic translation initiation factor 3, subunit B | 0.037 | ||
ADAM9 | ADAM metallopeptidase domain 9 | 0.037 | ||
YY1 | YY1 transcription factor | 0.037 | ||
S100A8 | S100 calcium binding protein A8 | 0.037 | ||
RMND5B | required for meiotic nuclear division 5 homolog B (S. cerevisiae) | 0.037 | ||
TLR3 | toll-like receptor 3 | 0.037 | ||
MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.036 | ||
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.036 | ||
WARS | tryptophanyl-tRNA synthetase | 0.036 | ||
CD226 | CD226 molecule | 0.036 | ||
FADD | Fas (TNFRSF6)-associated via death domain | 0.036 | ||
SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.036 | ||
FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.036 | ||
LGALS8 | lectin, galactoside-binding, soluble, 8 | 0.036 | ||
CCL17 | chemokine (C-C motif) ligand 17 | 0.036 | Human | |
CLDN18 | claudin 18 | 0.036 | ||
WDR11 | WD repeat domain 11 | 0.036 | ||
RIPK3 | receptor-interacting serine-threonine kinase 3 | 0.036 | ||
DDX3Y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked | 0.036 | ||
WNK1 | WNK lysine deficient protein kinase 1 | 0.036 | ||
MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.036 | ||
FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) | 0.036 | ||
IL9 | interleukin 9 | 0.036 | ||
HOXC8 | homeobox C8 | 0.036 | ||
ICK | intestinal cell (MAK-like) kinase | 0.035 | ||
LPXN | leupaxin | 0.035 | ||
H3F3B | H3 histone, family 3B (H3.3B) | 0.035 | ||
USP4 | ubiquitin specific peptidase 4 (proto-oncogene) | 0.035 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.035 | ||
MTRNR2L1 | MT-RNR2-like 1 | 0.035 | ||
MBOAT7 | membrane bound O-acyltransferase domain containing 7 | 0.035 | ||
KLF2 | Kruppel-like factor 2 (lung) | 0.035 | ||
POLR2G | polymerase (RNA) II (DNA directed) polypeptide G | 0.035 | ||
DES | desmin | 0.035 | ||
KPNA2 | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) | 0.035 | ||
FTSJD2 | FtsJ methyltransferase domain containing 2 | 0.035 | ||
PIAS2 | protein inhibitor of activated STAT, 2 | 0.035 | ||
KLF5 | Kruppel-like factor 5 (intestinal) | 0.035 | ||
SFTPD | surfactant protein D | 0.035 | Human | |
CLTB | clathrin, light chain B | 0.035 | ||
ICOS | inducible T-cell co-stimulator | 0.035 | ||
HIC1 | hypermethylated in cancer 1 | 0.035 | ||
IRF1 | interferon regulatory factor 1 | 0.035 | ||
MKI67 | antigen identified by monoclonal antibody Ki-67 | 0.035 | ||
DBR1 | debranching enzyme homolog 1 (S. cerevisiae) | 0.034 | ||
EPHB3 | EPH receptor B3 | 0.034 | ||
RAB11A | RAB11A, member RAS oncogene family | 0.034 | ||
IL18R1 | interleukin 18 receptor 1 | 0.034 | ||
MAPK3 | mitogen-activated protein kinase 3 | 0.034 | ||
TOMM40L | translocase of outer mitochondrial membrane 40 homolog (yeast)-like | 0.034 | ||
AP3S1 | adaptor-related protein complex 3, sigma 1 subunit | 0.034 | ||
NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.034 | ||
PDE9A | phosphodiesterase 9A | 0.034 | ||
HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 0.034 | ||
VPS28 | vacuolar protein sorting 28 homolog (S. cerevisiae) | 0.034 | ||
NDFIP2 | Nedd4 family interacting protein 2 | 0.034 | ||
STMN1 | stathmin 1 | 0.034 | ||
CHMP4A | chromatin modifying protein 4A | 0.034 | ||
NAT14 | N-acetyltransferase 14 (GCN5-related, putative) | 0.034 | ||
IL2RB | interleukin 2 receptor, beta | 0.034 | ||
SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.034 | ||
PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.034 | ||
MUC4 | mucin 4, cell surface associated | 0.034 | ||
GDI1 | GDP dissociation inhibitor 1 | 0.034 | ||
ATXN1 | ataxin 1 | 0.034 | ||
RNF185 | ring finger protein 185 | 0.034 | ||
FKBP4 | FK506 binding protein 4, 59kDa | 0.034 | ||
TFEC | transcription factor EC | 0.034 | ||
CCBP2 | chemokine binding protein 2 | 0.033 | ||
KDM6B | lysine (K)-specific demethylase 6B | 0.033 | ||
CDK4 | cyclin-dependent kinase 4 | 0.033 | ||
FAM20C | family with sequence similarity 20, member C | 0.033 | ||
MEOX2 | mesenchyme homeobox 2 | 0.033 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.033 | ||
OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.033 | ||
CXXC1 | CXXC finger protein 1 | 0.033 | ||
PTGES | prostaglandin E synthase | 0.033 | ||
SREBF2 | sterol regulatory element binding transcription factor 2 | 0.033 | ||
EGFL7 | EGF-like-domain, multiple 7 | 0.033 | ||
BUB1B | budding uninhibited by benzimidazoles 1 homolog beta (yeast) | 0.033 | ||
H1FX | H1 histone family, member X | 0.033 | ||
RCOR1 | REST corepressor 1 | 0.033 | ||
CD2BP2 | CD2 (cytoplasmic tail) binding protein 2 | 0.033 | ||
TBX21 | T-box 21 | 0.033 | ||
ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) | 0.033 | ||
CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.033 | ||
CD69 | CD69 molecule | 0.033 | ||
ATP6V1D | ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D | 0.033 | ||
ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.033 | ||
TRIM11 | tripartite motif containing 11 | 0.033 | ||
SLC22A13 | solute carrier family 22 (organic anion transporter), member 13 | 0.033 | ||
USP5 | ubiquitin specific peptidase 5 (isopeptidase T) | 0.033 | ||
SELL | selectin L | 0.033 | ||
NUDT1 | nudix (nucleoside diphosphate linked moiety X)-type motif 1 | 0.032 | ||
APOL1 | apolipoprotein L, 1 | 0.032 | ||
METTL23 | methyltransferase like 23 | 0.032 | ||
ZCCHC10 | zinc finger, CCHC domain containing 10 | 0.032 | ||
WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.032 | ||
ACTB | actin, beta | 0.032 | ||
SGK1 | serum/glucocorticoid regulated kinase 1 | 0.032 | ||
CCR9 | chemokine (C-C motif) receptor 9 | 0.032 | ||
SRSF2 | serine/arginine-rich splicing factor 2 | 0.032 | ||
RNF114 | ring finger protein 114 | 0.032 | ||
MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.032 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.032 | ||
RNF5 | ring finger protein 5 | 0.032 | ||
CMTM6 | CKLF-like MARVEL transmembrane domain containing 6 | 0.032 | ||
FOXA2 | forkhead box A2 | 0.032 | ||
CTDSP1 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 | 0.032 | ||
BAZ1B | bromodomain adjacent to zinc finger domain, 1B | 0.032 | ||
MFN1 | mitofusin 1 | 0.032 | ||
SFTPB | surfactant protein B | 0.032 | ||
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | 0.032 | ||
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.032 | ||
RNF181 | ring finger protein 181 | 0.032 | ||
CETN2 | centrin, EF-hand protein, 2 | 0.032 | ||
USP18 | ubiquitin specific peptidase 18 | 0.032 | ||
GMEB1 | glucocorticoid modulatory element binding protein 1 | 0.032 | ||
TUBGCP4 | tubulin, gamma complex associated protein 4 | 0.032 | ||
LEF1 | lymphoid enhancer-binding factor 1 | 0.031 | ||
LCN2 | lipocalin 2 | 0.031 | ||
ESRRG | estrogen-related receptor gamma | 0.031 | ||
MID2 | midline 2 | 0.031 | ||
RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.031 | ||
STRN3 | striatin, calmodulin binding protein 3 | 0.031 | ||
SMARCD1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.031 | ||
UPF3B | UPF3 regulator of nonsense transcripts homolog B (yeast) | 0.031 | ||
NCOA3 | nuclear receptor coactivator 3 | 0.031 | ||
CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.031 | ||
DDIT3 | DNA-damage-inducible transcript 3 | 0.031 | ||
ABCF1 | ATP-binding cassette, sub-family F (GCN20), member 1 | 0.031 | ||
REG3A | regenerating islet-derived 3 alpha | 0.031 |